statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	552
SG - Singapore	125
CN - Cina	121
HK - Hong Kong	57
BR - Brasile	50
GB - Regno Unito	42
SE - Svezia	32
VN - Vietnam	30
IT - Italia	24
DE - Germania	22
RU - Federazione Russa	21
FI - Finlandia	18
KR - Corea	13
FR - Francia	11
LT - Lituania	8
ID - Indonesia	7
NL - Olanda	7
ZA - Sudafrica	6
BG - Bulgaria	5
EC - Ecuador	5
EG - Egitto	5
IN - India	5
MX - Messico	5
JP - Giappone	4
PE - Perù	4
PL - Polonia	4
BD - Bangladesh	3
AR - Argentina	2
AT - Austria	2
CA - Canada	2
CO - Colombia	2
CZ - Repubblica Ceca	2
ES - Italia	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
BH - Bahrain	1
BO - Bolivia	1
GA - Gabon	1
GE - Georgia	1
HN - Honduras	1
IE - Irlanda	1
IL - Israele	1
IQ - Iraq	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
ML - Mali	1
MY - Malesia	1
NP - Nepal	1
PA - Panama	1
PH - Filippine	1
PY - Paraguay	1
RO - Romania	1
TH - Thailandia	1
TN - Tunisia	1
Totale	1.222

Nome	#
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon	232
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort	165
The epidemiology of hepatitis delta infection in Italy	154
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination	142
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B	132
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study	128
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications	106
Neutrophil–lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry	88
Molecular diagnostics in hepatitis C virus infection: Clinical applications	83
Totale	1.230

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	75	0	0	0	0	0	0	46	9	7	5	6	2
2021/2022	78	5	3	0	2	2	7	7	4	10	6	26	6
2022/2023	95	7	13	12	5	13	15	2	12	11	0	1	4
2023/2024	106	3	6	7	10	16	8	15	13	1	2	13	12
2024/2025	399	11	0	10	26	71	59	29	21	53	17	41	61
2025/2026	477	68	50	66	95	146	52	0	0	0	0	0	0
Totale													1.230